Hot Pursuit     23-Jan-23
Marksans Pharma gets UK MHRA approval for Fluoxetine oral solution
Marksans Pharma said that the UK MHRA has granted market authorisation to the company's wholly owned subsidiary Relonchem for Fluoxetine 20mg/5ml oral solution.

The drug maker said that the therapeutic use of the product is for treatment of depressive illness and other mental/mood disorders.

The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK.

Mumbai-based Marksans Pharma is engaged in the research, manufacturing & marketing of generic pharmaceutical formulations in the global markets.

The drug maker consolidated net profit rose 29.9% to Rs 60.12 crore on a 25.3% increase in revenue from operations to Rs 452.56 crore in Q2 FY23 over Q2 FY22.

The scrip fell 1.41% to currently trade at Rs 66.20 on the BSE.

Previous News
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
 ( Results - Announcements 13-Feb-23   14:08 )
  Marksans Pharma commences buyback of shares
 ( Corporate News - 15-Jul-22   17:50 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 31-May-23   12:46 )
  Marksans Pharma consolidated net profit rises 19.54% in the December 2019 quarter
 ( Results - Announcements 11-Feb-20   15:11 )
  Board of Marksans allots 5.03 cr equity shares on conversion of warrants
 ( Corporate News - 20-Jan-23   10:01 )
  Marksans Pharma consolidated net profit rises 86.01% in the March 2021 quarter
 ( Results - Announcements 31-May-21   14:16 )
  Marksans Pharma to discuss results
 ( Corporate News - 17-May-22   11:10 )
  Marksans Pharma gains on acquiring manufacturing facility from Tevapharm India
 ( Hot Pursuit - 19-Apr-23   12:07 )
  Marksans Pharma receives upgrade in credit ratings
 ( Corporate News - 30-Jun-21   14:00 )
  Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter
 ( Results - Announcements 11-Aug-21   17:29 )
Other Stories
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
Back Top